Literature DB >> 18522863

Estrogen anti-inflammatory activity in brain: a therapeutic opportunity for menopause and neurodegenerative diseases.

Elisabetta Vegeto1, Valeria Benedusi, Adriana Maggi.   

Abstract

Recent studies highlight the prominent role played by estrogens in protecting the central nervous system (CNS) against the noxious consequences of a chronic inflammatory reaction. The neurodegenerative process of several CNS diseases, including Multiple Sclerosis, Alzheimer's and Parkinson's Diseases, is associated with the activation of microglia cells, which drive the resident inflammatory response. Chronically stimulated during neurodegeneration, microglia cells are thought to provide detrimental effects on surrounding neurons. The inhibitory activity of estrogens on neuroinflammation and specifically on microglia might thus be considered as a beneficial therapeutic opportunity for delaying the onset or progression of neurodegenerative diseases; in addition, understanding the peculiar activity of this female hormone on inflammatory signalling pathways will possibly lead to the development of selected anti-inflammatory molecules. This review summarises the evidence for the involvement of microglia in neuroinflammation and the anti-inflammatory activity played by estrogens specifically in microglia.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18522863      PMCID: PMC2630539          DOI: 10.1016/j.yfrne.2008.04.001

Source DB:  PubMed          Journal:  Front Neuroendocrinol        ISSN: 0091-3022            Impact factor:   8.606


  264 in total

1.  17beta-estradiol antiinflammatory activity in carrageenan-induced pleurisy.

Authors:  S Cuzzocrea; S Santagati; L Sautebin; E Mazzon; G Calabrò; I Serraino; A P Caputi; A Maggi
Journal:  Endocrinology       Date:  2000-04       Impact factor: 4.736

2.  Uptake, degradation, and release of fibrillar and soluble forms of Alzheimer's amyloid beta-peptide by microglial cells.

Authors:  H Chung; M I Brazil; T T Soe; F R Maxfield
Journal:  J Biol Chem       Date:  1999-11-05       Impact factor: 5.157

Review 3.  The presenilins in Alzheimer's disease--proteolysis holds the key.

Authors:  C Haass; B De Strooper
Journal:  Science       Date:  1999-10-29       Impact factor: 47.728

4.  Neuronal overexpression of mutant amyloid precursor protein results in prominent deposition of cerebrovascular amyloid.

Authors:  M E Calhoun; P Burgermeister; A L Phinney; M Stalder; M Tolnay; K H Wiederhold; D Abramowski; C Sturchler-Pierrat; B Sommer; M Staufenbiel; M Jucker
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-23       Impact factor: 11.205

5.  Use of the brain parenchymal fraction to measure whole brain atrophy in relapsing-remitting MS. Multiple Sclerosis Collaborative Research Group.

Authors:  R A Rudick; E Fisher; J C Lee; J Simon; L Jacobs
Journal:  Neurology       Date:  1999-11-10       Impact factor: 9.910

6.  Effects of estrogen on nitric oxide synthase expression in rat aorta allograft and smooth muscle cells.

Authors:  S Saito; R S Aras; H Lou; P W Ramwell; M L Foegh
Journal:  J Heart Lung Transplant       Date:  1999-10       Impact factor: 10.247

7.  Estrogen improves motor disability in parkinsonian postmenopausal women with motor fluctuations.

Authors:  K L Tsang; S L Ho; S K Lo
Journal:  Neurology       Date:  2000-06-27       Impact factor: 9.910

8.  Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial. Alzheimer's Disease Cooperative Study.

Authors:  R A Mulnard; C W Cotman; C Kawas; C H van Dyck; M Sano; R Doody; E Koss; E Pfeiffer; S Jin; A Gamst; M Grundman; R Thomas; L J Thal
Journal:  JAMA       Date:  2000-02-23       Impact factor: 56.272

9.  Immunolocalization of estrogen receptor beta in the mouse brain: comparison with estrogen receptor alpha.

Authors:  Sudha Warrier Mitra; Elena Hoskin; Joel Yudkovitz; Lisset Pear; Hilary A Wilkinson; Shinji Hayashi; Donald W Pfaff; Sonoko Ogawa; Susan P Rohrer; James M Schaeffer; Bruce S McEwen; Stephen E Alves
Journal:  Endocrinology       Date:  2003-05       Impact factor: 4.736

10.  Estrogen receptor-alpha mediates the brain antiinflammatory activity of estradiol.

Authors:  Elisabetta Vegeto; Silvia Belcredito; Sabrina Etteri; Serena Ghisletti; Alessia Brusadelli; Clara Meda; Andrée Krust; Sonia Dupont; Paolo Ciana; Pierre Chambon; Adriana Maggi
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-23       Impact factor: 11.205

View more
  100 in total

1.  Estrogen and P2 Purinergic Receptor Systems in Microglia: Therapeutic Targets for Neuroprotection.

Authors:  Jessica M Crain; Jyoti J Watters
Journal:  Open Drug Discov J       Date:  2010-01-01

2.  17beta-estradiol protects male mice from cuprizone-induced demyelination and oligodendrocyte loss.

Authors:  Lorelei C Taylor; Kasturi Puranam; Wendy Gilmore; Jenny P-Y Ting; Glenn K Matsushima
Journal:  Neurobiol Dis       Date:  2010-03-27       Impact factor: 5.996

3.  Olfactory ERPs in an odor/visual congruency task differentiate ApoE ε4 carriers from non-carriers.

Authors:  Joel Kowalewski; Claire Murphy
Journal:  Brain Res       Date:  2011-12-20       Impact factor: 3.252

Review 4.  Cellular and molecular mechanisms of sexual differentiation in the mammalian nervous system.

Authors:  Nancy G Forger; J Alex Strahan; Alexandra Castillo-Ruiz
Journal:  Front Neuroendocrinol       Date:  2016-01-11       Impact factor: 8.606

5.  Modifications of neuroactive steroid levels in an experimental model of nigrostriatal degeneration: potential relevance to the pathophysiology of Parkinson's disease.

Authors:  Roberto Cosimo Melcangi; Donatella Caruso; Giovanna Levandis; Federico Abbiati; Marie-Therese Armentero; Fabio Blandini
Journal:  J Mol Neurosci       Date:  2011-06-14       Impact factor: 3.444

Review 6.  Development of subtype-selective oestrogen receptor-based therapeutics.

Authors:  Stefan Nilsson; Konrad F Koehler; Jan-Åke Gustafsson
Journal:  Nat Rev Drug Discov       Date:  2011-09-16       Impact factor: 84.694

7.  10β,17α-Dihydroxyestra-1,4-dien-3-one: A Bioprecursor Prodrug Preferentially Producing 17α-Estradiol in the Brain for Targeted Neurotherapy.

Authors:  Katalin Prokai-Tatrai; Vien Nguyen; Laszlo Prokai
Journal:  ACS Chem Neurosci       Date:  2018-06-05       Impact factor: 4.418

8.  Temporal and Site-Specific Changes in Central Neuroimmune Factors During Rapid Weight Gain After Ovariectomy in Rats.

Authors:  Kathleen S Curtis; Kelly McCracken; Enith Espinosa; Johnson Ong; Daniel J Buck; Randall L Davis
Journal:  Neurochem Res       Date:  2018-07-20       Impact factor: 3.996

9.  Neuroprotective actions of selective estrogen receptor modulators.

Authors:  Lydia L DonCarlos; Iñigo Azcoitia; Luis M Garcia-Segura
Journal:  Psychoneuroendocrinology       Date:  2009-12       Impact factor: 4.905

10.  Expression of P2 nucleotide receptors varies with age and sex in murine brain microglia.

Authors:  Jessica M Crain; Maria Nikodemova; Jyoti J Watters
Journal:  J Neuroinflammation       Date:  2009-08-25       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.